Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$828,981
+$350,186 QoQ
Shares Held
57,809
+12.5% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 158 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ZVRA ranks #149 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in ZVRA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $828,981 57,809
2026-03-31 $478,795 51,373
2025-12-31 $411,612 45,939
2025-09-30 $418,467 44,003
2025-06-30 $338,920 38,470
2025-03-31 $342,149 45,681
2024-12-31 $424,555 50,906
2024-09-30 $281,763 40,600
2024-06-30 $149,298 30,469
2024-03-31 $102,213 17,623
2023-12-31 $109,732 16,753
2023-09-30 $77,370 16,052
2022-03-31 $78,578 15,622
2021-12-31 $150,979 17,334
2021-09-30 $153,329 16,434
2021-06-30 $243,413 18,987